Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial

Zimmermann H, Koenecke C, Dreyling MH, Pott C, Duhrsen U, Hahn D, Meidenbauer N, Hauser IA, Rummel MJ, Wolf D, Heuser M, Schmidt C, Schlattmann P, Ritgen M, Siebert R, Oschlies I, Anagnostopoulos I, Trappe RU (2021)


Publication Type: Conference contribution

Publication year: 2021

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

DOI: 10.1182/blood-2021-146823

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Zimmermann, H., Koenecke, C., Dreyling, M.H., Pott, C., Duhrsen, U., Hahn, D.,... Trappe, R.U. (2021). Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial. In BLOOD. WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Zimmermann, Heiner, et al. "Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2021.

BibTeX: Download